DEPAKENE
BGP PHARMA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is DEPAKENE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that DEPAKENE 250MG has been permanently discontinued (last updated April 28, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is DEPAKENE not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MYLAN-VALPROIC
MYLAN PHARMACEUTICALS ULC
NOVO-VALPROIC
TEVA CANADA LIMITED
RATIO-VALPROIC
TEVA CANADA LIMITED
RATIO-VALPROIC-CAP 250MG
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
VALPROIC ACID
APOTEX INC
DOM-VALPROIC ACID
DOMINION PHARMACAL
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00443840
Strength
250MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.